International Clinical Trial: A single-arm, multicenter, open-label, phase II clinical study of Vedotin for injection as second-line or later treatment for advanced biliary tract cancer

Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133501) titled 'A single-arm, multicenter, open-label, phase II clinical study of Vedotin for injection as second-line or later treatment for advanced biliary tract cancer' on Sept. 28.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Jiangmen Central Hospital

Condition: Patients with primary advanced biliary tract cancer (BTC), including intrahepatic cholangiocarcinoma (ICC), extrahepatic cholangiocarcinoma (ECC), and gallbladder carcinoma (GBC) recurrent biliary tract cancer

Recruitment Status: Not Recruiting

Phase: 2

Date of First Enrollment: 2026-12-01

Target Sample Size: Investigational ...